- Updated: March 11, 2026
- 5 min read
Breakout Ventures Launches $114 Million AI‑Science Fund to Back Early‑Stage Science Startups
Breakout Ventures Raises $114M AI‑Science Fund to Accelerate Scientific Startups
Breakout Ventures has closed a $114 million Fund III dedicated to backing early‑stage startups that use artificial intelligence to solve complex problems in biology, chemistry, and other scientific domains.
Why This Fund Matters
The venture capital landscape is witnessing a surge of capital aimed at the intersection of AI and hard science. Breakout Ventures, a specialist firm that spun out of the Thiel Foundation’s grant program, is positioning itself at the forefront of this wave with a $114 million pool that targets startups capable of “unlocking the complexity of science with AI,” according to managing director Lindy Fishburne. The fund’s size, strategic focus, and early‑stage check range (from $500,000 to $5 million) signal a strong commitment to nurturing breakthrough innovations that could reshape drug discovery, materials engineering, and environmental science.
For venture capital investors, startup founders, and tech enthusiasts, understanding the composition and ambition of this fund provides a roadmap to the next generation of AI‑driven scientific breakthroughs.
Fund Overview
- Fund Size: $114 million (Fund III)
- Target Stage: Seed to Series A
- Check Size: $500 k – $5 M per company
- Portfolio Goal: At least 20 AI‑science startups
- Geographic Focus: Primarily North America, with selective global opportunities
The fund builds on two previous rounds—$60 million in 2017 (Fund I) and $112.5 million in 2021 (Fund II)—both of which were also dedicated to science‑focused AI ventures. By maintaining a consistent thematic focus, Breakout Ventures has cultivated deep domain expertise and a robust network of scientific founders, academic institutions, and industry partners.
Notable Limited Partners
The $114 million was raised over 18 months from a diversified group of limited partners (LPs) that share a long‑term vision for AI‑enabled science. Key LPs include:
The Kraft Group
A family‑owned conglomerate with a history of investing in high‑impact technology.
Pinegrove Venture Partners
Specializes in early‑stage AI and biotech investments.
S‑Cubed Capital
Focuses on deep‑tech ventures that combine AI with scientific research.
Other Institutional LPs
Including university endowments and sovereign wealth funds that prioritize transformative science.
Strategic Goals of the Fund
Breakout Ventures has articulated three core objectives for Fund III:
- Accelerate AI‑driven discovery: Provide capital and expertise to startups that can dramatically shorten R&D cycles in drug discovery, materials science, and environmental remediation.
- Build a collaborative ecosystem: Leverage the firm’s existing network—including the AI investments platform—to foster data sharing, joint experiments, and cross‑portfolio synergies.
- Generate outsized returns: Target breakthrough technologies that can create new markets, delivering multi‑digit returns for LPs while advancing societal good.
The fund’s strategy also emphasizes “founder‑first” sourcing. Breakout looks for PhDs and industry veterans who possess deep domain knowledge and a clear vision for how AI can solve a specific scientific bottleneck. As Fishburne explains, “We look for fit—the obvious reason why this is the best person to build a specific company.”
Impact on the AI‑Science Ecosystem
The infusion of $114 million will likely catalyze several trends:
- Increased Deal Flow: Early‑stage founders will have a dedicated source of capital, encouraging more scientists to spin out companies.
- Cross‑Domain Innovation: By connecting biotech, chemistry, and AI talent, the fund can spark hybrid solutions—e.g., AI‑guided synthesis of novel polymers for sustainable packaging.
- Talent Retention: Competitive funding reduces the brain‑drain from academia to big pharma, keeping cutting‑edge research within the startup ecosystem.
- Data Infrastructure Growth: Portfolio companies will need robust data pipelines, driving demand for platforms like the UBOS platform overview and its Workflow automation studio.
“AI is the microscope that will let us see the hidden patterns in biology and chemistry,” said Fishburne. “Our fund is the lens that brings those patterns into focus for entrepreneurs.”
The fund also dovetails with broader industry movements, such as the rise of AI‑enhanced laboratory automation and the growing adoption of large language models for hypothesis generation. As these technologies mature, the startups backed by Breakout Ventures will be well‑positioned to become the next wave of unicorns in the AI‑science space.
Further Reading & Resources
For a deeper dive into the fund’s announcement, see the original coverage on TechCrunch. To explore how AI investments are shaping scientific innovation, visit our science and technology hub.
Interested in building AI‑powered applications? Check out the AI investments page for templates like the AI SEO Analyzer or the AI Chatbot template. Our Enterprise AI platform by UBOS also offers scalable infrastructure for data‑intensive scientific workloads.
Conclusion
Breakout Ventures’ $114 million AI‑science fund represents a decisive vote of confidence in the power of artificial intelligence to accelerate scientific discovery. By targeting early‑stage founders with deep domain expertise, the fund not only promises attractive financial returns but also paves the way for breakthroughs that could address some of humanity’s most pressing challenges—from new medicines to sustainable materials. For investors, entrepreneurs, and technologists alike, the fund’s launch signals a fertile period for AI‑driven science—one that is worth watching closely.

Stay Informed
Subscribe to our newsletter for the latest updates on AI investments, scientific breakthroughs, and venture capital trends.